DNA vaccines: an historical perspective and view to the future

MA Liu - Immunological reviews, 2011 - Wiley Online Library
This review provides a detailed look at the attributes and immunologic mechanisms of
plasmid DNA vaccines and their utility as laboratory tools as well as potential human …

Toxin-based therapeutic approaches

A Shapira, I Benhar - Toxins, 2010 - mdpi.com
Protein toxins confer a defense against predation/grazing or a superior pathogenic
competence upon the producing organism. Such toxins have been perfected through …

Improving DNA vaccine performance through vector design

JA Williams - Current gene therapy, 2014 - ingentaconnect.com
DNA vaccines are a rapidly deployed next generation vaccination platform for treatment of
human and animal disease. DNA delivery devices, such as electroporation and needle free …

Lactococcus lactis as a cell factory for delivery of therapeutic proteins

M Bahey-El-Din, CGM Gahan, BT Griffin - Current gene therapy, 2010 - ingentaconnect.com
The food-grade bacterium Lactococcus lactis has been extensively investigated during the
last two decades as a delivery vector for therapeutic proteins, DNA and vaccine antigens …

Inhibitory effect of paeoniflorin on IgE-dependent and IgE-independent mast cell degranulation in vitro and vivo

Y Zhao, X Li, J Chu, Y Shao, Y Sun, Y Zhang, Z Liu - Food & Function, 2021 - pubs.rsc.org
The incidence of allergic diseases has increased to such a point that they have become
common and have reached epidemic levels. However, their pathogenesis is not fully …

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

A Jafarzadeh, P Chauhan, M Nemati… - Clinical & …, 2023 - Wiley Online Library
Suppressor of cytokine signalling (SOCS) proteins bind to certain cytokine receptors, Janus
kinases and signalling molecules to regulate signalling pathways, thus controlling immune …

A catch-and-release nano-based gene delivery system

CO Franck, AB Popov, I Ahmed, RE Hewitt… - Nanoscale …, 2023 - pubs.rsc.org
The design of nanomaterial-based nucleic acid formulations is one of the biggest
endeavours in the search for clinically applicable gene delivery systems. Biopolymers …

Type I IL‐1 receptor (IL‐1RI) as potential new therapeutic target for bronchial asthma

JH Lee, LC Wang, HH Yu, YT Lin… - Mediators of …, 2010 - Wiley Online Library
The IL‐1R/TLR family has been receiving considerable attention as potential regulators of
inflammation through their ability to act as either activators or suppressors of inflammation …

Gene therapy for allergic airway diseases

T Maes, KG Tournoy, GF Joos - Current allergy and asthma reports, 2011 - Springer
Airway diseases such as allergic asthma and rhinitis are characterized by a T-helper type 2
(Th2) response. Treatment of allergic airway diseases is currently limited to drugs that …

Efficacy and safety of moxibustion as a complementary and alternative therapy for asthma: A systematic review and meta-analysis

G Deng, X Feng, H Zhang, L Li, Q Cao, Y Fu… - International …, 2024 - Elsevier
Objective This systematic review of randomized controlled trials (RCTs) aimed to evaluate
the efficacy and safety of moxibustion as a complementary or alternative treatment for …